pre-eclampsia

D. Postpartum course. Hypertension due to preeclampsia resolves postpartum, often within a few days, but sometimes taking a few weeks.

If the swelling is sudden or moves to your hands and face, it may be a sign of a more serious condition called preeclampsia.

Unfortunately, we are unable to predict which of these gravidas will have superimposed preeclampsia and thus suffer added morbidity.

Conclusions: The sympathetic control of the blood pressure appear to be increased in women with preeclampsia.

Clinical manifestations of preeclampsia can appear anytime between the second trimester and the first few days postpartum.

Preeclampsia is one of the common complications of pregnancy, which is the leading cause of perinatal morbidity and mortality.

The researchers found the risks of developing preeclampsia dropped 10 percent among women taking aspirin or other antiplatelet medications.

The article reviewed progress in research on relationship between thrombophilia and varied types of preeclampsia, anticoagulant. . .

Conclusion The decreased expression of VEGF and PLGF in placenta tissues may be an important cause for preeclampsia and eclampsia.

Objective To investigate best of severe preeclampsia timing and manner of termination of pregnancy.

Preeclampsia occurs in up to 10 percent of all pregnancies, and is responsible for about 15 percent of pre-term births.

CONCLUSION: The change of genes expression in placenta is associated with the change of metabolism in patients suffering from preeclampsia.

Preliminary studies also suggest that calcium supplementation may lower blood pressure and prevent preeclampsia in pregnant women.

CRP, which is increased in pregnancy with preeclampsia, may be a sensitive biochemical marker for early diagnosing of preeclampsia.

Objective: To explore the influence of delivery outcome by severe preeclampsia complicated hypoproteinemia.

A. All women with severe preeclampsia should be delivered or hospitalized for the duration of pregnancy.

F. Women with severe preeclampsia should be delivered or hospitalized for the duration of pregnancy.

Objective To observe the changes of platelet derived growth factor (PDGFA) in patients with preeclampsia to explore its pathogenesis.

Methods We conducted a multicenter, randomized, double-blind trial involving nulliparous women who were at low risk for preeclampsia.

Objective To explore the impact of expectant management on the perinatal infantile outcome in early onset severe preeclampsia(ESPE).

cesarean section is the best way of severe preeclampsia to terminate the pregnancy.

The instrument can spot markers of runaway oxidation in a pregnant woman's body, an indicator of preeclampsia.

ButHypertensivePerson gravid and late unripe preeclampsia, placenta is inchoate come off the chance that waits for complication is more.

Increased maternal and fetal morbidity is associated with superimposed preeclampsia.

A. Screening. Pregnant women are routinely screened for signs and symptoms of preeclampsia at each prenatal visit.

Perinatal outcome was associated with the gestational weeks at onset of severe preeclampsia.

The study found that dark chocolate may help prevent a dangerous condition known as preeclampsia.

E. Eclampsia refers to the development of grand mal seizures in a woman with preeclampsia.

Severe preeclampsia that develops at 34 weeks of gestation is associated with high perinatal mortality and morbidity rates.

These patients have an increased risk of developing preeclampsia or eclampsia ( toxemia ) of pregnancy.

Delivery at or by 40 weeks of gestation should be considered for all women with preeclampsia.

In healthy primipara , preeclampsia incidence is about 6%, but 18% or higher in pregnant women ever contracted preeclampsia.

Preeclampsia is characterized by new onset of hypertension and proteinuria after 20 weeks of gestation.

Conclusion The prognosis of perineonates is closely related to severe preeclampsia timing and manner of termination of pregnancy.

A. The definitive treatment of preeclampsia is delivery.

Methods The data of 49 cases of early onset severe preeclampsia were retrospectively analyzed.

Objective: To investigate the best childbearing that is cesarean delivery in severe preeclampsia(S-PE)for safe mother and infant.

Mild preeclampsia includes those women who satisfy the criteria for preeclampsia but do not have any features of severe disease.

Polymorphism of SelS is closely associated with chronic inflammatory diseases such as diabetes, coronary heart disease and preeclampsia.

The perinatal mortality of preeclampsia patients whose gestational age was lower than 34 weeks was higher than that of more than 34 weeks.

It is very important to predict preeclampsia and its complications timely and accurately.

Preeclampsia is a kind of disease which contaminates seriously the life safety and quality of pregnant women and fetus.

Objective: To study the effects of timing delivery upon the perinatal outcome of the patients with severe preeclampsia.

Objective To study the effects of preeclampsia on perinatal outcome and prevention.

Study of the low-molecular-weight-heparin combined with routine therapies in treating the patients with severe preeclampsia

Study of maternal hemorheology changes and relationship between this changes and prognosis of fetus in preeclampsia

Clinical study of conservative management of early -onset severe preeclampsia

The interaction between lipid metabolism and blood coagulative-fibrinolytic activities in preeclampsia and normal pregnancy

Expression of gelatinase-B and its tissue inhibitor in trophoblast of preeclampsia and the clinical significance

Study of Placenta Growth Factor as An Early Marker for Development of Preeclampsia

Primary screening of preeclampsia related gene by suppression subtractive hybridization

Efficacy of Buprenorphine for Postoperative Epidural Analgesia in Patients with Severe Preeclampsia

Measurement of serum adiponectin and its significance in preeclampsia

Plasma and placental calcitonin gene - related peptide in pregnancies complicated by severe preeclampsia

The causes, manifestations and management of the cardiac diseases in preeclampsia and eclampsia

Clinical comparison between Urapidil and Phentolamine in treating severe preeclampsia

The Effects of Timing Delivery upon the Perinatal Outcome of Severe Preeclampsia Patients

Relationship between receptor for advanced glycation end products and preeclampsia

The value of the detection of cell-free fetal DNA in maternal plasma in the preeclampsia women using fluorescent quantitative PCR

Significance of increased fetal DNA concentration in maternal serum of preeclampsia patients

Relationship between chemokines and preeclampsia

Increasing of xanthine oxidase activity of placenta tissues result in oxidative stress in preeclampsia

Contribution of placental leptin to the serum levels in preeclampsia and effect of hypoxia on synthesis of placental leptin

Detection of Endothelial Nitric Oxide Synthase Gene Polymorphism in Preeclampsia

The monitoring and prevention for the complications of early type severe preeclampsia

The types and treatment of the cerebral vessels incidence in preeclampsia and eclampsia

Changes and clinical significance of serum leptin and soluble leptin receptor levels in preeclampsia

The Effect of Vascular Endothelial Growth Factor and Its Receptor in Kidney Lesion of Rats with Preeclampsia

A clinical analysis of severe preeclampsia complicated with fetal growth restriction

Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia

Comparison of serum leptin in peripheral circulation and uterine vein in patients with preeclampsia

Progress in study on relationship between hepatocyte growth factor and preeclampsia

Expression of Endothelial Nitric Oxide Synthase Gene in Placental Villus of Preeclampsia

Study of estradiol on treatment of preeclampsia in rat model

Anti -coagulation drugs for the prevention and treatment of preeclampsia

Altered expression of lipid metabolism-related genes ADRP and LPL in placental tissue of preeclampsia

Clinical characteristics and therapy of early-onset severe preeclampsia

Clinical analysis of expectant management on early onset severe preeclampsia

A research on abnormal signal transduction of trophoblast cells in preeclampsia

Study on different onset patterns and perinatal outcomes in severe preeclampsia

Study on unparalleled damage of end organs in severe preeclampsia and perinatal outcomes

The safety assessment of amniotic infusion therapy in severe preeclampsia

Study on NK cells in peripheral blood, umbilical blood and decidua of preeclampsia patients

Pregnant Outcome of Different Gestation Ages in Severe Preeclampsia of Early Onset

Screening of Severe Preeclampsia Related Gene Fragments

Study on the expression of LCHAD mRNA in placenta of normal pregnancy and sever preeclampsia

The effects of nitroglycerin on the severe preeclampsia pregnancy

Study on placental growth factor and nitric oxide in the pathogenesis of preeclampsia

Activities of Respiratory Chain Enzymes in the Etiology of Preeclampsia

The ultrasonic monitoring in severe preeclampsia

Preparation of preeclampsia rat model by ultra-low-dose endotoxin infusion

Clinical features and prognosis of early-onset preeclampsia

Role of Combination Treatment on Prevention of Preeclampsia

Level and significance of adiponection and oxidant low-density lipoproteins in serum of preeclampsia

Relationship between serum and placental interleukin-18 levels and preeclampsia

Influence of Preeclampsia on Perinatal Outcomes

The effects of preeclampsia on the perinatal outcome and prevention

Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester

Study on expression of heme oxygenase in human placenta of preeclampsia

Indications for Delivery in Preeclampsia

Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta

Preeclampsia Study Favors Earlier Birth

Latest advancement in the etiology of preeclampsia

The Effect of Plasma from Women with Preeclampsia on Endothelial Cells Activators in vitro

Results FN: The FN in patients with preeclampsia-eclampsia is higher than non-pregnancy women (P05) and normal late-pregnancy women (P01);

Can dexamethasone cure preeclampsia of Rat model

Study on Cell Apoptosis in the Placenta of Preeclampsia

Study on pregnancy terminating time in patients with preeclampsia

Analysis of maternal and neonatal outcome in 83 cases of severe preeclampsia

Analysis of Pregnancy outcome for 92 cases preeclampsia

B. Risk factors for preeclampsia:

Clinical Analysis of 38 Early on Set Severe Preeclampsia

The time and the way to stop pregnancy in severe preeclampsia and its outcome

Women who had suffered preeclampsia